BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 33634845)

  • 1. Sex-related impact on clinical outcomes of patients treated with drug-eluting stents according to clinical presentation: Patient-level pooled analysis from the GRAND-DES registry.
    Shin ES; Jun EJ; Han JK; Kong MG; Kang J; Zheng C; Garg S; Choi YJ; Bae JW; Chun KJ; Kim DI; Rha SW; Lee SY; Rhew JY; Woo SI; Lee HC; Jeong JO; Yang HM; Park KW; Kang HJ; Koo BK; Chae IH; Kim HS
    Cardiol J; 2023; 30(1):105-116. PubMed ID: 33634845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of Clinical Presentation (Stable Angina Pectoris vs Unstable Angina Pectoris or Non-ST-Elevation Myocardial Infarction vs ST-Elevation Myocardial Infarction) on Long-Term Outcomes in Women Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents.
    Giustino G; Baber U; Stefanini GG; Aquino M; Stone GW; Sartori S; Steg PG; Wijns W; Smits PC; Jeger RV; Leon MB; Windecker S; Serruys PW; Morice MC; Camenzind E; Weisz G; Kandzari D; Dangas GD; Mastoris I; Von Birgelen C; Galatius S; Kimura T; Mikhail G; Itchhaporia D; Mehta L; Ortega R; Kim HS; Valgimigli M; Kastrati A; Chieffo A; Mehran R
    Am J Cardiol; 2015 Sep; 116(6):845-52. PubMed ID: 26174605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of sex difference in clinical presentation (stable coronary artery disease vs unstable angina pectoris or non-ST-elevation myocardial infarction vs ST-elevation myocardial infarction) on 2-year outcomes in patients undergoing percutaneous coronary intervention.
    Tang XF; Song Y; Xu JJ; Ma YL; Zhang JH; Yao Y; He C; Wang HH; Jiang P; Jiang L; Liu R; Gao Z; Zhao XY; Qiao SB; Xu B; Yang YJ; Gao RL; Yuan JQ
    J Interv Cardiol; 2018 Feb; 31(1):5-14. PubMed ID: 29023996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of outcomes after percutaneous coronary intervention among different coronary subsets (stable and unstable angina pectoris and ST-segment and non-ST-segment myocardial infarction).
    Loh JP; Pendyala LK; Kitabata H; Torguson R; Omar A; Minha S; Chen F; Satler LF; Pichard AD; Waksman R
    Am J Cardiol; 2014 Jun; 113(11):1794-801. PubMed ID: 24837256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term Safety and Efficacy of New-Generation Drug-Eluting Stents in Women With Acute Myocardial Infarction: From the Women in Innovation and Drug-Eluting Stents (WIN-DES) Collaboration.
    Giustino G; Harari R; Baber U; Sartori S; Stone GW; Leon MB; Windecker S; Serruys PW; Kastrati A; Von Birgelen C; Kimura T; Stefanini GG; Dangas GD; Wijns W; Steg PG; Morice MC; Camenzind E; Weisz G; Smits PC; Sorrentino S; Sharma M; Farhan S; Faggioni M; Kandzari D; Galatius S; Jeger RV; Valgimigli M; Itchhaporia D; Mehta L; Kim HS; Chieffo A; Mehran R
    JAMA Cardiol; 2017 Aug; 2(8):855-862. PubMed ID: 28658478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term clinical outcomes in patients with unstable angina undergoing percutaneous coronary interventions in a contemporary registry data from Poland.
    Piątek Ł; Janion-Sadowska A; Piątek K; Zandecki Ł; Zabojszcz M; Siudak Z; Sadowski M
    Coron Artery Dis; 2020 May; 31(3):215-221. PubMed ID: 31821194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of renin-angiotensin system inhibitors on long-term clinical outcomes in patients with acute myocardial infarction treated with successful percutaneous coronary intervention with drug-eluting stents: Comparison between STEMI and NSTEMI.
    Kim YH; Her AY; Jeong MH; Kim BK; Lee SY; Hong SJ; Shin DH; Kim JS; Ko YG; Choi D; Hong MK; Jang Y
    Atherosclerosis; 2019 Jan; 280():166-173. PubMed ID: 30529829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gender differences and bleeding complications after PCI on first and second generation DES.
    Wanha W; Kawecki D; Roleder T; Pluta A; Marcinkiewicz K; Morawiec B; Kret M; Pawlowski T; Smolka G; Ochala A; Wojakowski W
    Scand Cardiovasc J; 2017 Feb; 51(1):53-60. PubMed ID: 27471987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stenting for ST-segment elevation myocardial infarction is associated with less neointimal hyperplasia in the pooled IVUS analysis from HORIZONS-AMI and the TAXUS IV and V and ATLAS workhorse, long lesion, and direct stent studies.
    Kobayashi N; Maehara A; Allocco D; Witzenbichler B; Ellis SG; Turco MA; Ormiston JA; Guagliumi G; Jiang S; McAndrew TC; Dawkins KD; Stone GW; Mintz GS; Weissman NJ
    Coron Artery Dis; 2014 Nov; 25(7):575-81. PubMed ID: 24911615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of outcomes of patients ≥ 80 years of age having percutaneous coronary intervention according to presentation (stable vs unstable angina pectoris/non-ST-segment elevation myocardial infarction vs ST-segment elevation myocardial infarction).
    Antonsen L; Jensen LO; Thayssen P; Christiansen EH; Junker A; Tilsted HH; Terkelsen CJ; Kaltoft A; Maeng M; Hansen KN; Ravkilde J; Lassen JF; Madsen M; Sørensen HT; Thuesen L
    Am J Cardiol; 2011 Nov; 108(10):1395-400. PubMed ID: 21890087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incomplete stent apposition and delayed tissue coverage are more frequent in drug-eluting stents implanted during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction than in drug-eluting stents implanted for stable/unstable angina: insights from optical coherence tomography.
    Gonzalo N; Barlis P; Serruys PW; Garcia-Garcia HM; Onuma Y; Ligthart J; Regar E
    JACC Cardiovasc Interv; 2009 May; 2(5):445-52. PubMed ID: 19463469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of Long-Term Outcomes in Men versus Women Undergoing Percutaneous Coronary Intervention.
    Murphy AC; Dinh D; Koshy AN; Lefkovits J; Clark DJ; Zaman S; Duffy SJ; Brennan A; Reid C; Yudi MB;
    Am J Cardiol; 2021 Aug; 153():1-8. PubMed ID: 34238448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and Safety of Stents in ST-Segment Elevation Myocardial Infarction.
    Chichareon P; Modolo R; Collet C; Tenekecioglu E; Vink MA; Oh PC; Ahn JM; Musto C; Díaz de la Llera LS; Cho YS; Violini R; Park SJ; Suryapranata H; Piek JJ; de Winter RJ; Wykrzykowska JJ; Spaulding C; Kang WC; Slagboom T; Hofma SH; Wijnbergen IF; Di Lorenzo E; Pijls NH; Räber L; Brugaletta S; Sabaté M; Stoll HP; Stone GW; Windecker S; Onuma Y; Serruys PW
    J Am Coll Cardiol; 2019 Nov; 74(21):2572-2584. PubMed ID: 31753202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of newer-generation drug-eluting with bare-metal stents in patients with acute ST-segment elevation myocardial infarction: a pooled analysis of the EXAMINATION (clinical Evaluation of the Xience-V stent in Acute Myocardial INfArcTION) and COMFORTABLE-AMI (Comparison of Biolimus Eluted From an Erodible Stent Coating With Bare Metal Stents in Acute ST-Elevation Myocardial Infarction) trials.
    Sabaté M; Räber L; Heg D; Brugaletta S; Kelbaek H; Cequier A; Ostojic M; Iñiguez A; Tüller D; Serra A; Baumbach A; von Birgelen C; Hernandez-Antolin R; Roffi M; Mainar V; Valgimigli M; Serruys PW; Jüni P; Windecker S
    JACC Cardiovasc Interv; 2014 Jan; 7(1):55-63. PubMed ID: 24332419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug-eluting versus bare-metal stents in large coronary arteries of patients with ST-segment elevation myocardial infarction: findings from the ICAS registry.
    Abe D; Sato A; Hoshi T; Maruta S; Misaki M; Kakefuda Y; Watabe H; Hiraya D; Sakai S; Kawabe M; Takeyasu N; Aonuma K
    J Cardiol; 2014 Nov; 64(5):377-83. PubMed ID: 24685689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term outcomes of patients receiving zotarolimus-eluting stents in ST elevation myocardial infarction, non-ST elevation acute coronary syndrome, and stable angina: data from the Resolute program.
    Widimsky P; Motovska Z; Belardi J; Serruys P; Silber S; Windecker S; Neumann FJ
    Int J Cardiol; 2013 Oct; 168(4):3522-6. PubMed ID: 23706326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of stent generation on 2-year clinical outcomes in ST-segment elevation myocardial infarction patients with multivessel disease who underwent culprit-only or multivessel percutaneous coronary intervention.
    Kim YH; Her AY; Jeong MH; Kim BK; Hong SJ; Kim JS; Ko YG; Choi D; Hong MK; Jang Y
    Catheter Cardiovasc Interv; 2020 Feb; 95(2):E40-E55. PubMed ID: 31423723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term outcome after drug-eluting versus bare-metal stent implantation in patients with ST-segment elevation myocardial infarction: 5 years follow-up from the randomized DEDICATION trial (Drug Elution and Distal Protection in Acute Myocardial Infarction).
    Holmvang L; Kelbæk H; Kaltoft A; Thuesen L; Lassen JF; Clemmensen P; Kløvgaard L; Engstrøm T; Bøtker HE; Saunamäki K; Krusell LR; Jørgensen E; Tilsted HH; Christiansen EH; Ravkilde J; Køber L; Kofoed KF; Terkelsen CJ; Helqvist S
    JACC Cardiovasc Interv; 2013 Jun; 6(6):548-53. PubMed ID: 23683734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Three-year outcomes related to coronary stenting; a registry-based real-life population study.
    Piuhola J; Holmström LTA; Niemelä M; Kervinen K; Tulppo M; Asikainen R; Hypèn L; Junttila MJ
    Scand Cardiovasc J; 2020 Jun; 54(3):162-168. PubMed ID: 31752551
    [No Abstract]   [Full Text] [Related]  

  • 20. Long-term effects of drug-eluting stents versus bare metal stents on patients with acute ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: outcomes of 3-year clinical follow-up.
    Wang CH; Fang Q; Zhang SY; Shen ZJ; Fan ZJ; Jin XF; Zeng Y; Liu ZY; Xie HZ; Yang M
    Chin Med J (Engl); 2012 Aug; 125(16):2803-6. PubMed ID: 22932070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.